Skip to main content

Bio-Techne, 908 Devices Partner on Protein Characterization

NEW YORK – Bio-Techne and 908 Devices said on Tuesday that they are jointly developing an extended workflow for protein characterization.

Specifically, the firms plan to pair Minneapolis-based Bio-Techne's Maurice icIEF protein separation instrument with Boston-based 908 Devices' ZipChip platform, enabling in-depth characterization of intact and near-native biotherapeutics.

908 Devices' open-access ZipChip platform enables high-resolution separation and mass spec sample introduction. It directly integrates electrospray ionization with mass spectrometry and is compatible with Thermo Fisher Scientific, Sciex, and Bruker mass spectrometers. ZipChip uses capillary electrophoresis and electrospray ionization technology to minimize sample prep burden, perform high-resolution separations, and directly introduce samples into a mass spec instrument, according to the firms.

"By partnering with Bio-Techne and leveraging their market leading Maurice icIEF platform with our ZipChip device, we are together extending the workflow for customers conducting detailed protein characterization of charge variants," said Kevin Knopp, CEO and cofounder of 908 Devices, in statement. "This collaboration helps advance our reach into the biopharmaceutical market."

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.